MacroGenics, Inc. a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer,...
Read moreiMedrix, a Silicon Valley and Bangalore-based mHealth start-up, announced the general availability of its product KardioScreen, a CE certified mobile/portable...
Read moreSouth Texas Research Accelerated Therapeutics (START) and Sarah Cannon Research Institute announced a new collaboration to complement and enhance their...
Read moreBioProtect, the technology leader in biodegradable balloon spacers protecting normal tissue during radiation therapy, announced the launch of its clinical...
Read moreThermo Fisher Scientific Inc., the world leader in serving science, announced today that manufacturing of Zilrettaâ„¢, is underway at its...
Read moreCrown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational...
Read moreThermo Fisher Scientific and Illumina, Inc. announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq...
Read moreMedivir AB, a research-based pharmaceutical company, announced the successful completion of the pre-clinical safety studies for MIV-818 to enable the...
Read moreAkcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious...
Read moreAvelas Biosciences, a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.